Skip to main content
OpenTrials

Clinical trial condition

Acquired Immunodeficiency Syndrome

Explore clinical trials studying Acquired Immunodeficiency Syndrome. Study availability and eligibility vary by location and protocol.

2,558 public trials 178 recruiting studies
Refine in advanced search Browse all conditions

Acquired Immunodeficiency Syndrome trial results

Completed

Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women

NCT02858037

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Johns Hopkins University Research Project Blantyre, Malawi
  • Malawi Clinical Research Center Lilongwe, Malawi
  • Medical Research Council of South Africa Westville, Durban, South Africa
  • WRHI Clinical Research Center Johannesburg, Gauteng, South Africa
View all 17 locations
View Trial Details
Completed

Study of Dapivirine Vaginal Ring (VR) in Adolescents

NCT02028338

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Alabama CRS 84519th street south, BBRB 203A Birmingham, Alabama, United States
  • The university of Colorado, 13123 E. 16th Ave., Box 025 Aurora, Colorado, United States
  • The University of Colorado; 13123 E. 16th Ave., Box 025 Aurora, Colorado, United States
  • The Fenway Institute, 1340 Boylston Street Boston, Massachusetts, United States
View Trial Details
Completed

Prospective Observational Epidemiologic Study of Maraviroc's Safety

NCT00665561

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Health Services Center Hobson City, Alabama, United States
  • AAC/Davis Clinic Huntsville, Alabama, United States
  • Alabama Infectious Diseases Center Huntsville, Alabama, United States
  • Office of Franco Antonio Felizarta MD Bakersfield, California, United States
View all 269 locations
View Trial Details
Completed

Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)

NCT04799353

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Franco Felizarta, Md /Id# 223931 Bakersfield, California, United States
  • Ruane Clinical Research Group /ID# 224496 Los Angeles, California, United States
  • Quest Clinical Research /ID# 223925 San Francisco, California, United States
  • Central Texas Clinical Research /ID# 223937 Austin, Texas, United States
View Trial Details

Related conditions